Asmau Nasiru Hamza

Dr. Asmau Nasiru Hamza


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
YJYusuf Jimoh
Yusuf Jimoh
IAIdris Yunusa Abdullah
Idris Yunusa Abdullah
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
MAmaryam abdullahi
maryam abdullahi
AOAhmadu Jibril Oludare
Ahmadu Jibril Oludare
ZSZukhruf Salami
Zukhruf Salami
Malaria, a devastating disease caused by Plasmodium parasites, continues to pose a significant threat to global health, with increasing resistance to current antimalarial drugs. In this study, we employed an in silico approach to design and evaluate novel 2-pyrazoline carboxamide derivatives as potential protease inhibitors against Plasmodium falciparum. Our results show that all the designed ligands exhibit good drug-like properties, satisfying Lipinski’s rule of five, and have low toxicity profiles. Molecular docking studies revealed that five newly designed ligands (P5, P6, P7, P11, and P13) exhibit promising binding affinities and interactions with key protease enzymes involved in the hemoglobin degradation pathway, including Falcipain-2, Falcipain-3, and Plasmepsin-2 with PDB (Protein Data Bank) codes of 6JW9, 3BWK, and 1LF3, respectively. Notably, ligand P13 showed the strongest binding affinity with Falcipain-2, forming an additional hydrogen bond with CYS42, an essential residue for the enzyme’s catalytic activity. The interactions between the ligands and the enzymes suggest a competitive inhibition mechanism, with the potential to disrupt the hemoglobin degradation pathway and halt the parasite’s lifecycle. The biological implications of these findings are significant, as they suggest that these novel ligands could be effective against Plasmodium parasites, particularly in the context of increasing resistance to current antimalarial drugs. Overall, this study provides valuable insights into the potential of novel 2-pyrazoline carboxamide derivatives to serve as protease inhibitors against Plasmodium parasites, highlights their potential as a promising strategy for antimalarial drug development, and demonstrates the importance of in silico approaches in the discovery of novel therapeutics.

14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
HBHASSAN ALI BILA
HASSAN ALI BILA
BBBashar Bawa
Bashar Bawa
MAmaryam abdullahi
maryam abdullahi
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HSHassan Halimatu Sadiya
Hassan Halimatu Sadiya
Malaria remains a critical global health challenge, particularly affecting Sub-Saharan Africa. Plasmepsins, vital in hydrolyzing peptide bonds within proteins, present promising targets for antimalarial drugs. Plasmepsins I and II, key aspartic proteases, are crucial in various parasite processes. This study investigates the inhibitory properties of quercetin, quercetrin, dihydrostilbene, 4′-methoxy-isoliquiritigenin, and stigmasterol from Globimetula oreophila on plasmepsins through in silico techniques, including ADME predictions and molecular docking. Results reveal strong interactions of these compounds with active site residues, with quercetrin and stigmasterol displaying notable binding affinities. These findings suggest the potential of G. oreophila metabolites as potent plasmepsin inhibitors, offering prospects for malaria treatment and prevention.

14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
HKHamza Karimatu
Hamza Karimatu
IYIdris Abdullahi Yunusa
Idris Abdullahi Yunusa
MMMuhammad Aliyu Musa
Muhammad Aliyu Musa
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HAHamza Sa’adatu Auwal
Hamza Sa’adatu Auwal
MAmaryam abdullahi
maryam abdullahi
Throughout history to the present day, infectious diseases have been a persistent global threat, causing significant harm to public health and economic stability. To address these challenges, the development of novel antimicrobial drugs is crucial. Hydrazones have gained significant attention in the scientific literature as promising candidates for developing new antimicrobial drugs. Two new hydrazones (H3 and H4) incorporating moieties that are known to enhance antimicrobial activity were synthesized. Methods: Hydrazone derivatives were synthesized through a condensation reaction of substituted acetophenone and nitro phenyl hydrazine. The compounds were characterized by their melting points and spectral analyses, including FT-IR, 1H NMR, 13C NMR, and 2D NMR. Their antibacterial effects on Escherichia coli and Staphylococcus aureus were assessed in-vitro using the agar diffusion and broth dilution methods. Results: In-vitro testing demonstrated the compounds’ good activity against the tested organisms, particularly Gram-positive bacteria. At a concentration of 50 mg/mL, H3 produced a zone of inhibition (19 mm) comparable to that of the standard ciprofloxacin (20 mm) at 0.05 mg/mL. Only H3 was able to kill both Staphylococcus aureus and Escherichia coli at a concentration of 50 mg/mL. In all cases, H3 was found to be the most effective with optimum bactericidal and bacteriostatic activity against staphylococcus aureus and Escherichia coli. Conclusions: All the synthesized compounds were proven to possess promising antibacterial activity in vitro against the tested organisms.

25 August 2019
Verified
Journal Article
Open access
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
AIAbdullahi Idris
Abdullahi Idris
AMAliyu Musa
Aliyu Musa
AOAmina Olorukooba
Amina Olorukooba
A peer-reviewed, open access online international journal which publishes original research papers. The journal welcomes submission from scholars and experts for possible publication from all over the world. The scope of the journal includes: Pharmaceutical research, chemistry and biochemistry of naturally occurring compounds, biological evaluation of crude extracts, ethnomedicine, traditional and complementary medicine, ethnopharmacology, biomedical research, Biotechnology, Evaluation of natural substances of land and sea and of plants, microbes and animals, pharmacognosy, bioavailability, clinical, pharmacological, toxicological studies and pharmacokinetics of phytochemicals, Isolation and characterization of compounds, structure elucidation, synthesis and experimental biosynthesis of natural Product as well as developments of methods in these areas are welcomed in the journal.

2 July 2025 in Sciences of Phytochemistry
Verified
Journal Article
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
BABila Hassan Ali
Bila Hassan Ali
BBBashar Bawa
Bashar Bawa
MAmaryam abdullahi
maryam abdullahi
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HHHalimatu Sadiya Hassan
Halimatu Sadiya Hassan
Malaria remains a major global health challenge due to its high morbidity and mortality, further complicated by growing antimalarial drug resistance. Natural products are being increasingly explored as potential sources of new therapies, with malarial proteases emerging as promising targets due to their essential roles in parasite development, invasion, egress, and hemoglobin degradation. This study evaluates the inhibitory potential of five compounds, quercetrin (DG1), dihydrostilbene (DG2), 4′-methoxy-isoliquiritigenin (DG3), stigmasterol (DG4), and quercetin (DG5), isolated from Globimetula oreophila leaves, using in silico docking against Plasmodium falciparum enzymes. Targets included falcipain-2 and falcipain-3 (cysteine proteases), SERA5 (hemoglobin-processing enzyme), PfDHFR-TS (bifunctional enzyme), and PfCDPK2 (kinase). Docking revealed strong binding affinities through hydrogen bonds, van der Waals forces, and hydrophobic interactions. DG4 showed a high affinity for PfDHFR (-10.3 kcal/mol), comparable to cycloguanil (-10.7 kcal/mol), while DG1 bound firmly to falcipain-2 (-7.9 kcal/mol), falcipain-3 (-7.5 kcal/mol), and PfCDPK2 (-9.0 kcal/mol). Binding to SERA5 ranged from -6.0 to -6.8 kcal/mol. These findings suggest that the tested compounds may act as inhibitors of vital P. falciparum enzymes, holding promise for the development of antimalarial drugs.

15 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
Rabiu BakoRabiu Bako
Rabiu Bako
AIAbdullahi Yunusa Idris
Abdullahi Yunusa Idris
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
GAGbonjubola O. Adeshina
Gbonjubola O. Adeshina
MGMusa Abdullahi Garba
Musa Abdullahi Garba
Antimicrobial chemotherapeutic failure as a result of pathogenic resistance stain is great concern across the globe, there is need to search for an effective antimicrobial agent from synthetic sources to overcome emergent of microbial resistant in clinical practice. The phenylhydrazone derivatives were scientifically found to have wide application in the field of drug discovery due to their anticancer, anti-tubercular, antibacterial, and antifungal activities. The (E)-Substituted-N-(phenylhydrazones) derivatives were obtained by a condensation reaction between substituted acetophenone and substituted phenyl hydrazine through a one-step reaction, resulting of five (5) novel compounds such as HS1 (E)-1-(1-(4-bromophenyl)ethylidene)-2-(2,4-dinitrophenyl)hydrazine), HS2(E)-1-(1-(4-bromophenyl)ethylidene)-2-(4-nitrophenyl)hydrazine), HS3(E)-1-(4-nitrophenyl)-2-(1-(3-nitrophenyl)ethylidene)hydrazine), HS4(E)-1-(2,4-dinitrophenyl)-2-(1-(3-nitrophenyl)ethylidene)hydrazine), and HS5 (E)-1-(1-(3-nitrophenyl)ethylidene)-2-phenylhydrazine) and the in-silico prediction of physicochemical properties were found within Lipinski’s rule of five and the synthesized compounds were established by structurally elucidations on the basis of FTIR, 1D and 2D NMR spectral analysis and the newly synthesized compounds were then subjected to antimicrobial assessment for an in vitro test evaluation using the inhibition zone technique, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC).